iTeos Therapeutics (ITOS)
(Delayed Data from NSDQ)
$18.05 USD
+0.15 (0.84%)
Updated May 17, 2024 04:00 PM ET
After-Market: $18.05 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
iTeos Therapeutics, Inc. [ITOS]
Reports for Purchase
Showing records 81 - 100 ( 108 total )
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Inupadenant Monotherapy Continues to Show Clinical Benefit; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
EOS-850 Hints at Potential Patient Selection
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
ASCO 2021 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Inupadenant Data Update Imminent; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
''448: Top TIGIT to Twosomes, Taking on Titans
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
A Tickle of Activity with anti-TIGIT Antibody
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: iTeos Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Will ITOS Show Best-In-Class Anti-TIGIT Monotherapy Data at AACR?
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D